FDA Extends Deadline for Enforcing 5 Percent Limit on Out-of-State Distribution of Compounded Human Drug Products

Summary

The Food and Drug Administration (FDA) is extending the deadline to enforce a 5 percent limit on the distribution of compounded human drug products out of state, originally set for October 27, 2022, until the publication of a final rule and an updated Memorandum of Understanding (MOU)